Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
OccuLogix, Inc. is a health care company that brings innovative medical therapies to market. We recently launched the RHEOTM procedure (Rheopheresis) – a blood filtration procedure used in the treatment of the dry form of age-related macular degeneration. AMD is the #1 cause of blindness in people over 50. To find out more about the RHEOTM procedure (Rheopheresis) , please visit Rheo.com ( www.occulogix.com )
OccuLogix , Inc.
8 Saint Mary’s Street Suite 629
Boston, Massachusetts 02215
USA
Tel: (800) 939-7659
Fax: (617) 358-1933